PHARMACY

AAM said Medicaid inflation penalties exacerbate challenges faced by generic drug manufacturers.

Prescription Cost Tracker will monitor out-of-pocket prescription spending trends in the United States.

Meitheal has exclusive U.S. rights to Yusimry and responsibility for all commercial activities nationally.

Prochlorperazine edisylate injection is indicated to treat nausea and vomiting as well as the treatment of schizophrenia.

Customers now have two options when seeking care from Amazon One Medical: pay per visit telehealth or membership.

The top three reasons Americans would go to a convenient care facility rather than their primary care doctor are immediate availability, faster service and convenience, per the survey.

WBA lowered its fiscal 2024 adjusted EPS guidance to $2.80 to $2.95 reflecting challenging pharmacy industry trends and a worse-than-expected U.S. consumer environment.

The Biosimilars Council is calling for inclusion of an affirmative statement to allow for a better understanding of treatment options and more affordable medicines.